Ishikawa Eiichi 石川栄一

… Alternative Names

ISHIKAWA Eiichi 石川栄一

Less

Researcher Number	30510169
Other IDs
Affiliation (Current)	2025: 筑波大学, 医学医療系, 教授
Affiliation (based on the past Project Information) *help	2021 – 2024: 筑波大学, 医学医療系, 教授 2017 – 2021: 筑波大学, 医学医療系, 准教授 2015 – 2016: 筑波大学, 医学医療系, 講師 2011 – 2012: 筑波大学, 医学医療系, 講師 2009 – 2010: 筑波大学, 大学院・人間総合科学研究科, 講師
Review Section/Research Field	Principal Investigator Basic Section 56010:Neurosurgery-related / Neurosurgery / Cerebral neurosurgery Except Principal Investigator Basic Section 56010:Neurosurgery-related / Basic Section 50020:Tumor diagnostics and therapeutics-related / Cerebral neurosurgery
Keywords	Principal Investigator 悪性神経膠腫 / 免疫療法 / PD-L1 / 免疫チェックポイント分子 / グリオーマ / immunotherapy / glioma / 脳腫瘍 / 神経膠腫 / ホウ素中性子捕捉療法 … More / 放射線療法 / 放射線力学的治療 / radiodynamic therapy / 蛍光力学療法 / 放射線力学療法 / iPS / 再発 / 血管新生 / 予後因子 / PI3Kγ阻害剤 / マクロファージ / 脳腫瘍学 / PD-1 / glioma stem cell / immune checkpoint / ワクチン療法 / 血管内皮細胞 / ワクチン / 癌幹細胞 / 脳神経外科 / 悪性脳腫瘍 / 脳神経疾患 / 免疫学 / 血管内皮前駆細胞 … More Except Principal Investigator glioma / 脳動静脈シャント / 血管新生阻害剤徐放性人工硬膜 / tumor targeting / active tumor targeting / gold / boron / nanoparticles / carboranes / BNCT / liposomes / 多角的免疫療法 / PD-L1 / 免疫チェックポイント / 制御性T細胞 / グリオーマ / 不活化ウイルス粒子 / 内皮細胞ワクチン / metronomic treatment / low molecular weight heparin / bevacizumab / CXCR7 / SDF-1 / 光線力学療法 / Notchシグナル / siRNA / マイクロアレイ / 神経膠腫 / 腫瘍微小環境 / 抵抗性 / ケモカイン / 腫瘍内皮細胞 / 血管新生 / 膠芽腫 Less

Elucidation and Overcoming the Mechanism of Immune Cell Inactivation after Combination of Advanced Local Therapy and Immunotherapy for GlioblastomaPrincipal Investigator
- Principal Investigator
  
  石川栄一
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Development of a novel multifunctional nanoliposome-based system for maintaining active agent concentration in tumor tissue during boron-neutron capture therapy
- Principal Investigator
  
  ザボロノクアレクサンドル
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  University of Tsukuba
血管新生阻害剤徐放性人工硬膜による脳動静脈シャント疾患に対する新規治療の確立
- Principal Investigator
  
  伊藤嘉朗
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Combination therapy of radiodynamic therapy with porphyrin compounds and immunotherapy for gliomaPrincipal Investigator
- Principal Investigator
  
  石川栄一
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Development of multifaceted immunotherapy for glioma using inactivated viral particle
- Principal Investigator
  
  Matsuda Masahide
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Mechanism of immune cell inactivation using glioma stem cells and iPS cellsPrincipal Investigator
- Principal Investigator
  
  Ishikawa Eiichi
- Project Period (FY)
  2018 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Combination of Immune checkpoint inhibitors and vaccine in glioma stem cellPrincipal Investigator
- Principal Investigator
  
  Ishikawa Eiichi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Neurosurgery
- Research Institution
  University of Tsukuba
Vaccine therapy using EPC with gene modificationPrincipal Investigator
- Principal Investigator
  
  ISHIKAWA Eiichi
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Cerebral neurosurgery
- Research Institution
  University of Tsukuba
Progress of anti-angiogenic therapy for brain tumors : new modality and resolution of the resistance
- Principal Investigator
  
  TAKANO Shingo
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Cerebral neurosurgery
- Research Institution
  University of Tsukuba

All 2021 2020 2019 2018 2017 2016 2013 2012 2011 2010 2009 Other

All Journal Article Presentation

[Journal Article] Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy2021
- Author(s)
  Ishikawa Eiichi、Miyazaki Tsubasa、Takano Shingo、Akutsu Hiroyoshi
- Journal Title
  
  Brain Tumor Pathology
  
  Volume: 38 Issue: 3 Pages: 149-155
- DOI
  10.1007/s10014-021-00402-5
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08962
[Journal Article] Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma2020
- Author(s)
  Sugii Narushi、Matsuda Masahide、Okumura Genki、Shibuya Akira、Ishikawa Eiichi、Kaneda Yasufumi、Matsumura Akira
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 1 Pages: 81-90
- DOI
  10.1111/cas.14721
- NAID
  120007178959
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08988, KAKENHI-PROJECT-21H04836
[Journal Article] Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells2020
- Author(s)
  Miyazaki Tsubasa、Ishikawa Eiichi、Matsuda Masahide、Sugii Narushi、Kohzuki Hedihiro、Akutsu Hiroyoshi、Sakamoto Noriaki、Takano Shingo、Matsumura Akira
- Journal Title
  
  Brain Tumor Pathology
  
  Volume: 37 Issue: 2 Pages: 41-49
- DOI
  10.1007/s10014-020-00357-z
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08962
[Journal Article] Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment2020
- Author(s)
  Miyazaki Tsubasa、Ishikawa Eiichi、Sugii Narushi、Matsuda Masahide
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 7 Pages: 1960-1960
- DOI
  10.3390/cancers12071960
- NAID
  120007180746
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08962
[Journal Article] CXCL12/CXCR4 signaling in glioma stem cells; prospects for therapeutic intervention2017
- Author(s)
  Miyazaki T, Uemae Y, Ishikawa E
- Journal Title
  
  Translational Cancer Research
  
  Volume: 6 (Suppl. 2) Issue: S2 Pages: 434-437
- DOI
  10.21037/tcr.2017.03.63
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K10327
[Journal Article] CAR-T cell in vivo tracking method using PET scan with the reporter gene and new investigational tracer [18F] FHBG2017
- Author(s)
  Miyazaki T, Aiyama H, Ishikawa E
- Journal Title
  
  Translational Cancer Research
  
  Volume: 6 (Suppl. 6) Issue: S6 Pages: 1003-1005
- DOI
  10.21037/tcr.2017.06.50
- NAID
  120007133485
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K10327
[Journal Article] Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome2017
- Author(s)
  Miyazaki Tsubasa、Ishikawa Eiichi、Matsuda Masahide、Akutsu Hiroyoshi、Osuka Satoru、Sakamoto Noriaki、Takano Shingo、Yamamoto Tetsuya、Tsuboi Koji、Matsumura Akira
- Journal Title
  
  Journal of Neuro-Oncology
  
  Volume: 133 Issue: 2 Pages: 277-285
- DOI
  10.1007/s11060-017-2451-7
- NAID
  120007128861
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04947, KAKENHI-PROJECT-16H05387, KAKENHI-PROJECT-15K10327, KAKENHI-PROJECT-16K15573
[Journal Article] Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy2017
- Author(s)
  Ishikawa E, Yamamoto T, Matsumura A
- Journal Title
  
  Neurol. Med. Chir.(Tokyo)
  
  Volume: 57 Issue: 7 Pages: 321-330
- DOI
  10.2176/nmc.nmc.ra.2016-0334
- NAID
  130005773952
- ISSN
  0470-8105, 1349-8029
- Language
  English
- Data Source
  KAKENHI-PROJECT-15K10327
[Journal Article] Glioma Immunotherapy With Combined Autologous Tumor Cell and Endothelial Cell Vaccine In Vivo2012
- Author(s)
  Sakamoto N, Uemae Y, Ishikawa E, Takano S, Nakai K, Yamamoto T, Zaboronok A, Matsuinura A.
- Journal Title
  
  Neurol Med Chir (Tokyo)
  
  Volume: (in press)
- NAID
  10030127755
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791332
[Journal Article] Glioma Immunotherapy With Combined Autologous Tumor Cell and Endothelial Cell Vaccine In Vivo2012
- Author(s)
  Sakamoto N, Uemae Y, Ishikawa E, Takano S, Nakai K, Yamamoto T, Zaboronok A, Matsumura A.
- Journal Title
  
  Neurol. Med. Chir.(Tokyo)
  
  Volume: 52 Issue: 4 Pages: 194-201
- DOI
  10.2176/nmc.52.194
- NAID
  10030127755
- ISSN
  0470-8105, 1349-8029
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791332
[Journal Article] Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain2012
- Author(s)
  Osuka S, Takano S, Watanabe S, Ishikawa E, Yamamoto T, Matsumura A
- Journal Title
  
  Neurol Med Chir (Tokyo)
  
  Volume: 52 Pages: 186-193
- NAID
  10030127723
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Immunohistochemical detection of IDH1 mutation, p53 and internexin as a prognostic marker of glial tumors2012
- Author(s)
  Takano S, Kato Y, Yamamoto T, Kaneko MK, Ishikawa E, Tsujimoto Y, Matsuda M, Nakai K, Yanagiya R, Morita S, Tsuboi K, Matsumura A
- Journal Title
  
  J Neurooncol in press
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Glioma immunotherapy with combined autologous tumor celland endothelial vaccination in vivo2012
- Author(s)
  Sakamoto N, Uemae Y, Ishikawa E, Takano S, Nakai K, Yamamoto T, Zaboronok A, Matsumura A
- Journal Title
  
  Neurol Med Chir (Tokyo)
  
  Volume: 52 Pages: 194-201
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Glioma Immunotherapy With Combined Autologous Tumor Cell and Endothelial Cell Vaccine In Vivo2012
- Author(s)
  Sakamoto N, Uemae Y, Ishikawa E, Takano S, Nakai K, Yamamoto T, Zaboronok A, Matsumura A
- Journal Title
  
  Neurol Med Chir (Tokyo)
  
  Volume: 52 Pages: 194-201
- NAID
  10030127755
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791332
[Journal Article] Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy.2011
- Author(s)
  Matsuda M, Takano S, Ishikawa E, et al.
- Journal Title
  
  British Journal of Radiology
  
  Volume: (In press)
- NAID
  120007137315
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Hypoxia-inducible factor 1 a expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image.2011
- Author(s)
  Mashiko R, Takano S, Ishikawa E, et al.
- Journal Title
  
  Journal of Neurooncology
  
  Volume: 102 Pages: 43-50
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolo mide for glioblastoma. three case reports-2011
- Author(s)
  Sakamoto N, Ishikawa E, Yamamoto T, Satomi K, Nakai K, Sato M, Enomoto T, Morishita Y, Takano S, Ohno T, Tsuboi K, Matsumura A
- Journal Title
  
  Neurol Med Chir (Tokyo)
  
  Volume: 51 Pages: 319-325
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Detection of IDH1 mutation in human ghomas : comparison of immunoh istochemistry and sequencing.2010
- Author(s)
  Takano S, Ishikawa E, et al.
- Journal Title
  
  Brain Tumor Pathology
  
  Volume: 27
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Low peripheral lymphocyte count before focal radiotherapy plus concomitant temozolomide predicts severe lymphopenia during malignant glioma treatment.2010
- Author(s)
  Ishikawa E, Takano S, et al
- Journal Title
  
  Neurol Med Chir (Tokyo)
  
  Volume: 50 Pages: 638-644
- NAID
  10026651306
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Metronomic treatment of malignant glioma xenografts with irinotecan(CPT-11)inhibits angiogenesis and tumor growth2010
- Author(s)
  高野晋吾, 石川栄一, 他
- Journal Title
  
  Journal of Neurooncology (In press)(印刷中)
- NAID
  120007137939
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] 悪性脳腫瘍に対するヒト脳腫瘍由来血管内皮細胞ワクチン治療2010
- Author(s)
  高野晋吾、石川栄一, ら
- Journal Title
  
  がん治療のあゆみ
  
  Volume: 29 Pages: 7-12
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Detection of failure of bevacizumab treatment for malignant glioma based on urinary matrix metalloproteinase activity.2010
- Author(s)
  Takano S, Ishikawa E, Ohneda O, et al.
- Journal Title
  
  Brain Tumor Pathology
  
  Volume: 27 Pages: 89-94
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Detection of failure of bevacizumab treatment formalignant glioma based on urinary matrix metalloproteinase activity2010
- Author(s)
  Takano S, Mashiko R, Osuka S, Ishikawa E, Ohneda O, Matsumura A
- Journal Title
  
  Brain Tumor Pathol
  
  Volume: 27 Pages: 89-94
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth2010
- Author(s)
  Takano S, Kamiyama H, Mashiko R, Osuka S, Ishikawa E, Matsumura A
- Journal Title
  
  J Neurooncol
  
  Volume: 99 Pages: 177-185
- NAID
  120007137939
- Data Source
  KAKENHI-PROJECT-21390403
[Journal Article] 悪性脳腫瘍に対するヒト脳腫瘍由来血管内皮細胞ワクチン治療2010
- Author(s)
  高野晋吾、石川栄一, 他
- Journal Title
  
  がん治療のあゆみ 29
  
  Pages: 7-12
- Data Source
  KAKENHI-PROJECT-21390403
[Presentation] PD-L1に対するsiRNAを封入したHVJ-Eはマウス神経膠腫に対し抗腫瘍免疫反応を惹起する2021
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一
- Organizer
  第39回日本脳腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 不活化センダイウイルス粒子と腫瘍PD-L1発現阻害は局所での免疫抑制を二重に解除し神経膠腫に対する抗腫瘍免疫を惹起する2020
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  日本脳神経外科学会第79回学術総会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 制御性Tリンパ球抑制と腫瘍PD-L1発現阻害の併用による悪性神経膠腫に対する免疫抑制的腫瘍微小環境の改善2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 腫瘍PD-L1発現阻害と制御性Tリンパ球抑制の併用による新たな抗腫瘍免疫療法の開発2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第37回日本脳腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 腫瘍PD-L1発現阻害と制御性Tリンパ球抑制の併用による悪性神経膠腫に対する新規抗腫瘍免疫療法の開発2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第57回ニューロ・オンコロジィの会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 制御性Tリンパ球抑制と腫瘍PD-L1発現阻害の併用による悪性神経膠腫に対する新たな抗腫瘍免疫療法の開発2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第20回日本分子脳神経外科学会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 腫瘍PD-L1発現阻害と制御性Ｔリンパ球抑制の併用による悪性神経膠腫に対する新たな抗腫瘍免疫療法の開発2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第78回日本脳神経外科学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 腫瘍 PD-L1 発現阻害と制御性Ｔリンパ球抑制の併用による新たな抗腫瘍免疫療法の開発2018
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第36回日本脳腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 再発膠芽腫におけるPD-1発現上昇と再発後の予後2017
- Author(s)
  5.石川栄一、松田真秀、宮崎　翼、高野晋吾、阿久津博義、松村　明
- Organizer
  第35回日本脳腫瘍学会
- Data Source
  KAKENHI-PROJECT-15K10327
[Presentation] 膠芽腫に対する腫瘍ワクチン療法の経過とPD-1抗体療法併用の可能性2017
- Author(s)
  7.石川栄一、松田真秀、宮崎　翼、阿久津博義、高野晋吾、松村　明
- Organizer
  第76回日本脳神経外科学会総会
- Data Source
  KAKENHI-PROJECT-15K10327
[Presentation] 悪性神経膠腫に対する治療～免疫療法のトピックスも含め～2017
- Author(s)
  石川栄一
- Organizer
  脳腫瘍治療セミナー2017
- Invited
- Data Source
  KAKENHI-PROJECT-15K10327
[Presentation] Multicenter randomized placebo-controlled trial of autologous formalin-fixed tumor vaccine for newly-diagnosed glioblastomas2017
- Author(s)
  2.Muragaki Y, Maruyama T, Ishikawa E, Nitta M, Ikuta S, Tsuboi K, Matsumura A, Nakamura H, Abe T, Saito R, Tabei Y, Arakawa Y, Momii Y, Matsutani M, Karasawa K, Nakazato Y, Ohno T, Maebayashi K
- Organizer
  SNO2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10327
[Presentation] 膠芽腫に対する腫瘍ワクチン療法とPD-1抗体療法との併用2016
- Author(s)
  石川栄一　他
- Organizer
  第75回日本脳神経外科総会
- Place of Presentation
  福岡県福岡市　福岡国際会議場
- Year and Date
  2016-09-29
- Data Source
  KAKENHI-PROJECT-15K10327
[Presentation] 膠芽腫に対する腫瘍免疫療法後の腫瘍再発と組織中のPD-1/PD-L1分子発現2016
- Author(s)
  石川栄一　他
- Organizer
  第34回日本脳腫瘍学会学術集会
- Place of Presentation
  山梨県甲府市　甲府富士屋ホテル
- Year and Date
  2016-12-04
- Data Source
  KAKENHI-PROJECT-15K10327
[Presentation] 悪性神経膠腫瘍に対するSDF-1(CXCL-12)/CXCR-4 を標的とした新規治療の開発2013
- Author(s)
  石川栄一、上前洋二、松田真秀、大須賀覚、山本哲哉、高野晋吾、松村明
- Organizer
  第8回脳腫瘍の基礎シンポジウム
- Place of Presentation
  東京
- Year and Date
  2013-03-02
- Data Source
  KAKENHI-PROJECT-22791332
[Presentation] 不活化ウイルス粒子による悪性脳腫瘍治療の開発-免疫療法としての側面2012
- Author(s)
  松田真秀、小沼邦之、石川栄一、金田安史、松村明
- Organizer
  第9回がんワクチン療法研究会(AsCaVaTh)学術集会
- Place of Presentation
  つくば
- Year and Date
  2012-11-17
- Data Source
  KAKENHI-PROJECT-22791332
[Presentation] CXCL12 Targeting Therapy for Glioma Using a Murine Brain Tumor-Initiating Cell-line2012
- Author(s)
  Uemae Y, Ishikawa E, Osuka S,MatsudaM, Sakamoto N, Takano S, Nakai K, Yamamoto T, Saya H, Matsumura A
- Organizer
  The 3rdLeading Graduate Schools International Conference
- Place of Presentation
  Tsukuba
- Year and Date
  2012-11-02
- Data Source
  KAKENHI-PROJECT-22791332
[Presentation] マウス Brain Tumor-initiating Cell-line (BTICs)を用いた分子標的療法の開発2012
- Author(s)
  石川栄一
- Organizer
  第30回日本脳腫瘍学会
- Place of Presentation
  広島
- Data Source
  KAKENHI-PROJECT-22791332
[Presentation] マウス Brain Tumor-initiating Cell-line (BTICs)を用いた分子標的療法の開発2012
- Author(s)
  石川栄一、上前洋二、大須賀覚、松田真秀、坂本規影、高野晋吾、中井啓、山本哲哉、松村明
- Organizer
  第30回日本脳腫瘍学会学術集会
- Place of Presentation
  広島
- Year and Date
  2012-11-27
- Data Source
  KAKENHI-PROJECT-22791332
[Presentation] ウイルスエンベロープを用いたdrug delivery systemの開発2011
- Author(s)
  松田真秀,金田安史,石川栄一,中井啓,山本哲哉,高野晋吾,松村明
- Organizer
  第70回日本脳神経外科学会総会
- Place of Presentation
  横浜
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-22791332
[Presentation] 1p/19q LOH解析とMGMT発現にもとづいたグリオーマの治療戦略2010
- Author(s)
  高野晋吾、石川栄一, ら
- Organizer
  第48回日本癌治療学会
- Place of Presentation
  京都
- Year and Date
  2010-10-28
- Data Source
  KAKENHI-PROJECT-21390403
[Presentation] マウスグリオーマ皮下モデルを用いた同種血管内皮細胞ワクチン療法の研究2010
- Author(s)
  石川栄一、坂本規彰、上前洋二、山本哲哉、高野晋吾、松村明
- Organizer
  第28回脳腫瘍学会
- Place of Presentation
  軽井沢
- Year and Date
  2010-11-30
- Data Source
  KAKENHI-PROJECT-22791332
[Presentation] 再発悪性神経膠腫対するVEGF中和抗体の効果と抵抗性の克服へ2010
- Author(s)
  高野晋吾、石川栄一, ら
- Organizer
  第40回ニューロオンコロジーの会
- Place of Presentation
  東京
- Year and Date
  2010-12-04
- Data Source
  KAKENHI-PROJECT-21390403
[Presentation] The role of chemokine SDF-1/CXCR4/CXCR7 for glioblastoma angiogenesis and glioblastoma derived endothelial cells2009
- Author(s)
  Takano S, Ema M, Ohneda O, Ishikawa E etal
- Organizer
  The 3^<rd> Quadrennial Meeting of the WFNO
- Place of Presentation
  横浜
- Year and Date
  2009-05-11
- Data Source
  KAKENHI-PROJECT-21390403
[Presentation] SDF-1 and CXCR7 are key molecules for glioma angiogenesis and invasiveness2009
- Author(s)
  高野晋吾, Ema M, 石川栄一, 大根田修, et al.
- Organizer
  第68回日本癌学会
- Place of Presentation
  横浜
- Year and Date
  2009-10-01
- Data Source
  KAKENHI-PROJECT-21390403
[Presentation] 低分子ヘパリンによるグリオーマ血管新生抑制2009
- Author(s)
  高野晋吾、石川栄一, 他
- Organizer
  第27回日本脳腫瘍学会
- Place of Presentation
  大阪
- Year and Date
  2009-11-08
- Data Source
  KAKENHI-PROJECT-21390403
[Presentation] グリオーマに対するVEGF中和抗体の作用機序:血管新生抑制と腫瘍細胞のアポトーシス増強2009
- Author(s)
  高野晋吾, 石川栄一, 他
- Organizer
  第27回日本脳腫瘍学会
- Place of Presentation
  大阪
- Year and Date
  2009-11-08
- Data Source
  KAKENHI-PROJECT-21390403
[Presentation] SDF-1 and CXCR7 are key molecules for glioma angiogenesis and invasiveness2009
- Author(s)
  Takano S, Ema M, Ishikawa E, Ohneda O etal
- Organizer
  第68 回日本癌学会
- Place of Presentation
  横浜
- Year and Date
  2009-10-01
- Data Source
  KAKENHI-PROJECT-21390403
[Presentation] 悪性神経膠腫瘍に対するSDF-1（CXCL-12）/CXCR-4を標的とした新規治療の開発
- Author(s)
  石川栄一
- Organizer
  第８回脳腫瘍の基礎シンポジウム
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-22791332

1. Matsuda Masahide (30614333)

# of Collaborated Projects: 6 results

# of Collaborated Products: 17 results
2. 坪井康次 (90188615)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
3. 松井裕史 (70272200)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. 鶴淵隆夫 (70778901)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. TAKANO Shingo (50292553)

# of Collaborated Projects: 1 results

# of Collaborated Products: 22 results
6. OHNEDA Osamu (30311872)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
7. EMA Masatsugu (60359578)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
8. KUBOTA Yoshiaki (50348687)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 伊東史子 (70502582)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 伊東進 (70223154)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 三木俊一郎 (10774036)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. ザボロノクアレクサンドル (20723117)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 白川真 (40707759)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 中井啓 (50436284)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. MATHIS BRYAN (80794635)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 伊藤嘉朗 (90733014)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 細尾久幸 (20897623)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. 大矢根綾子 (50356672)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. 松丸祐司 (70323300)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 坂本規彰

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
21. 上前洋二

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
22. MATSUDA Wakoto

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ishikawa Eiichi 石川 栄一

ISHIKAWA Eiichi 石川 栄一

Research Projects

Research Products

Co-Researchers

Elucidation and Overcoming the Mechanism of Immune Cell Inactivation after Combination of Advanced Local Therapy and Immunotherapy for GlioblastomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a novel multifunctional nanoliposome-based system for maintaining active agent concentration in tumor tissue during boron-neutron capture therapy

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

血管新生阻害剤徐放性人工硬膜による脳動静脈シャント疾患に対する新規治療の確立

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Combination therapy of radiodynamic therapy with porphyrin compounds and immunotherapy for gliomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of multifaceted immunotherapy for glioma using inactivated viral particle

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of immune cell inactivation using glioma stem cells and iPS cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Combination of Immune checkpoint inhibitors and vaccine in glioma stem cellPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Vaccine therapy using EPC with gene modificationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Progress of anti-angiogenic therapy for brain tumors : new modality and resolution of the resistance

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment2020

Author(s)

Journal Title

DOI

NAID

Ishikawa Eiichi 石川栄一

ISHIKAWA Eiichi 石川栄一